Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Nahum Méndez-Sánchez"'
Autor:
Norberto Chávez-Tapia, Jorge Torres-Sánchez, Juan Romero-Flores, Paulina Álvarez-Quiroz, Sandra Ramírez-Álvarez, Eva Juárez-Hernández, José Pérez-Jáuregui, Nahum Méndez-Sánchez, Misael Uribe
Publikováno v:
Annals of Hepatology, Vol 14, Iss 4, Pp 524-530 (2015)
Background. Transient elastography (TE) is a useful tool for the assessment of hepatic fibrosis as an alternative to liver biopsy, but it has not been validated as a screening procedure in apparently healthy people.Aim. To determine the prevalence of
Externí odkaz:
https://doaj.org/article/db4d85cb9a554e20b12de85feb4aa346
Autor:
Ileana MacKinney-Novelo, Josué Barahona-Garrido, Fátima Castillo-Albarran, Jean J Santiago-Hernández, Nahum Méndez-Sánchez, Misael Uribe, Norberto Chávez-Tapia
Publikováno v:
Annals of Hepatology, Vol 11, Iss 5, Pp 652-657 (2012)
Background. Hepatitis A is the most common type of viral hepatitis in Mexico. The change of hepatitis A epidemiology in Mexico from high to intermediate endemicity leads to increasing susceptible adults for severe illness. Objective. To describe the
Externí odkaz:
https://doaj.org/article/25998773c9d04d05b304d46027b41257
Autor:
Nahum Méndez-Sánchez, Daniel Motola-Kuba, Daniel Zamora-Valdés, Karla Sánchez-L ara, Guadalupe Ponciano-Rodríguez, Martha H. Uribe-Ramos, Francisco Vásquez-Fernández, Jezer Lezama-Mora, Julio A. Pérez-Sosa, Héctor A. Baptista-González, Misael Uribe
Publikováno v:
Annals of Hepatology, Vol 5, Iss 4, Pp 276-280 (2006)
Background & aim: Alcohol consumption and viral infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) are the first causes of chronic hepatopathy in Mexico. Medical personnel are at high risk of developing HBV and HCV infection because b
Externí odkaz:
https://doaj.org/article/2fb7e66610f94f5aa39c8c8d931d1752
Autor:
Jiahui Pan, Yuwei Liu, Xiaozhong Guo, Zhaohui Bai, Giovanni Battista Levi Sandri, Nahum Méndez-Sánchez, Xingshun Qi
Publikováno v:
Expert opinion on drug safety. 21(10)
Immune checkpoint inhibitors (ICIs) are effective for the treatment of various cancers, but can lead to immune-mediated hepatotoxicity (IMH). The aim of this study was to analyze the risk factors for IMH in cancer patients treated with ICIs.The PubMe
Autor:
Juan Pablo Arab, Javier Diaz-Ferrer, Marcos Girala, Marcelo Silva, Eduardo Fassio, Juan Carlos Restrepo, Melisa Dirchwolf, Martín Padilla-Machaca, Marlen Ivón Castellanos Fernández, Mario G. Pessoa, Claudia P. Oliveira, Aldo Torre, Ezequiel Ridruejo, Lucy Dagher, Helma Pinchemel-Cotrim, Misael Uribe, Marco Arrese, Manuel Gatica, Norberto C. Chávez-Tapia, Adrián Gadano, Nahum Méndez-Sánchez, Blanca Olaechea
Publikováno v:
The Lancet Gastroenterology & Hepatology. 6:65-72
The Latin American Association for the Study of the Liver (Asociación Latinoamericana para el Estudio del Hígado; ALEH) represents liver professionals in Latin America with the mission of promoting liver health and quality patient care by advancing
Autor:
Luis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, Francisco Idalsoaga, Jorge Arnold, Andrea Márquez-Lomas, Carolina A Ramírez, María Paz Medel, Francisca Viñuela, Lucas Lacalle, Juan Pablo Roblero, Catterina Ferreccio, Mariana Lazo, Mayur Brahmania, Ashwani K Singal, Melisa Dirchwolf, Nahum Méndez-Sánchez, Norberto Chavez-Tapia, Patricia Guerra, Juan Carlos Restrepo, Claudia P Oliveira, Julissa Lombardo, Abel Sánchez, Martín Elizondo, Martín Tagle, Martín Padilla, Marco Sánchez, Enrique Carrera, Marcos Girala, Omega Chery, Marlen Castellanos-Fernández, Francisco Barrera, Jeffrey V Lazarus, Patrick S Kamath, Ramon Bataller, Marco Arrese, Juan Pablo Arab
Non-alcoholic fatty liver disease (NAFLD) affects 20-25% of the general population and is associated with morbidity, increased mortality, and elevated health-care costs. Most NAFLD risk factors are modifiable and, therefore, potentially amenable to b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc05d1088f084348971eb7e3d97cf44
https://hdl.handle.net/20.500.12866/11872
https://hdl.handle.net/20.500.12866/11872
Publikováno v:
The Lancet Gastroenterology & Hepatology. 5:713-715
Autor:
Alvaro Urzúa, Fernando Contreras, Juan Pablo Roblero, Helena Cortez-Pinto, Douglas A. Simonetto, Aldo Torre, Vijay H. Shah, Fernando Bessone, Ramon Bataller, Michael R. Lucey, Nahum Méndez-Sánchez, Juan Carlos Restrepo, Fátima Higuera-de la Tijera, Juan G. Abraldes, Juan Pablo Arab, José Altamirano, Roberta Chaves Araújo
Publikováno v:
Annals of Hepatology, Vol 18, Iss 3, Pp 518-535 (2019)
Alcohol-related liver disease (ALD) is a major cause of advanced chronic liver disease in Latin-America, although data on prevalence is limited. Public health policies aimed at reducing the alarming prevalence of alcohol use disorder in Latin-America
Autor:
A. Torre-Delgadillo, Francisco Bosques-Padilla, M.F. Higuera de la Tijera, Heriberto Rodríguez-Hernández, J.A. Chávez-Barrera, P. Ramos-Martínez, Y. Gutiérrez-Grobe, M.S. González-Huezo, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Stoopen-Rometti, J.L. Poo-Ramírez, S.E. Martínez-Vázquez, Ramón Carmona-Sánchez, D. Kershenobich-Stalnikowitz, G.E. Castro-Narro, J. Flores-Calderón, E. Márquez-Guillén, R. Bernal-Reyes, R. Malé-Velázquez, Juan Francisco Sánchez-Ávila, Norberto C. Chávez-Tapia, Ignacio García-Juárez, R. Trejo-Estrada, M.A. Ballesteros-Amozurrutia, Carlos A. Aguilar-Salinas, Diego Garcia-Compean, Javier Lizardi-Cervera, R. Moreno-Alcántar, I. Aiza-Haddad, M. Uribe-Esquivel, Nahum Méndez-Sánchez, J.A. Velarde-Ruiz Velasco, Gonzalo Torres-Villalobos, J.A. López-Cossio, L. Ladrón de Guevara-Cetina
Publikováno v:
Revista de Gastroenterología de México (English Edition), Vol 84, Iss 1, Pp 69-99 (2019)
Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk factors for the disease and its prevalence could surpass 50%. If immediate action is not t
Autor:
Raymundo Paraná, Manuel Mendizabal, Nelia Hernández, Ezequiel Ridruejo, Fernando Contreras, Marco Arrese, Martín Tagle, Mario G. Pessoa, Eduardo Fassio, Nahum Méndez-Sánchez, Fernando Bessone, Marcelo Silva, Javier Brahm, Lucy Dagher
Publikováno v:
Annals of Hepatology, Vol 24, Iss, Pp 100321-(2021)
Idiosyncratic drug-induced liver injury (DILI) caused by xenobiotics (drugs, herbals and dietary supplements) is an uncommon cause of liver disease presenting with a wide range of phenotypes and disease severity, acute hepatitis mimicking viral hepat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127fd0492ab0f18e04fb017cb1424561
https://hdl.handle.net/20.500.12866/9121
https://hdl.handle.net/20.500.12866/9121